skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Dihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expression

Journal Article · · Biochemical and Biophysical Research Communications
; ; ; ; ; ; ; ;  [1]; ;  [2]; ; ;  [3];  [4];  [1]
  1. Department of Biochemistry and Institute for Medical Sciences, Chonbuk National University, Medical School, Jeonju, Jeonbuk 560-182 (Korea, Republic of)
  2. Department of Surgery, Chonbuk National University, Medical School, Jeonju, Jeonbuk 560-182 (Korea, Republic of)
  3. Department of Companion and Laboratory Animal Science, Kongju National University, Yesan 340-702 (Korea, Republic of)
  4. Division of Animal Science and Resources Research Center for Transgenic Cloned Pigs, Chungnam National University, Daejeon 305-764 (Korea, Republic of)

Research highlights: {yields} MMP-9 plays a pivotal role in the invasion of MCF-7 breast cancer cells. {yields} TPA stimulates MMP-9 expression through activation of MAPK/NF-{kappa}B and MAPK/AP-1 pathways. {yields} Dihydroavenanthramide D suppresses MMP-9 expression via inhibition of TPA-induced MAPK/NF-{kappa}B and MAPK/AP-1 activations. {yields} Dihydroavenanthramide D blocks cell invasion of MCF-7 breast cancer cells. -- Abstract: Dihydroavenanthramide D (DHAvD) is a synthetic analog to naturally occurring avenanthramide, which is the active component of oat. Previous study demonstrates that DHAvD strongly inhibits activation of nuclear factor-kappa B (NF-{kappa}B), which is a major component in cancer cell invasion. The present study investigated whether DHAvD can modulate MMP-9 expression and cell invasion in MCF-7 human breast cancer cells. MMP-9 expression and cell invasion in response to 12-O-tetradecanoylphorbol-13-acetate (TPA) was increased, whereas these inductions were muted by DHAvD. DHAvD also suppressed activation of mitogen-activated protein kinase (MAPK), and MAPK-mediated nuclear factor-kappa B (NF-{kappa}B) and activator protein-1 (AP-1) activations in TPA-treated MCF-7 cells. The results indicate that DHAvD-mediated inhibition of TPA-induced MMP-9 expression and cell invasion involves the suppression of the MAPK/NF-{kappa}B and MAPK/AP-1 pathways in MCF-7 cells. DHAvD may have potential value in breast cancer metastasis.

OSTI ID:
22204806
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 405, Issue 4; Other Information: Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells
Journal Article · Fri Jun 01 00:00:00 EDT 2012 · Toxicology and Applied Pharmacology · OSTI ID:22204806

The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells
Journal Article · Fri Jun 22 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:22204806

Metastatic function of BMP-2 in gastric cancer cells: The role of PI3K/AKT, MAPK, the NF-{kappa}B pathway, and MMP-9 expression
Journal Article · Fri Jul 15 00:00:00 EDT 2011 · Experimental Cell Research · OSTI ID:22204806